MoleMate: Until Now it has Been Extremely Difficult to Bring Uniformity to Diagnosis Melanomas

Oct. 11, 2011 - PRLog -- Whether based on the expertise of the dermatologist, built up over years of specialization, or the ‘gut reaction’ of a GP seeing something new, it is extremely difficult to bring uniformity to diagnosis and treatment monitoring where the skin is concerned.

Many dermatologists and GPs say that one of the main problems of diagnosing and monitoring pigmented lesions is the issue of subjectivity. When two people look at the same, non-uniform object, the chances are that they will not describe its color and shape in exactly the same way. When two digital photographs of the same subject are taken, without complicated equipment and procedures there will be subtle differences in lighting, angle and distance to the object, all things that can make the two pictures appear non-identical.

Up until now, getting simply a more detailed look at the surface of the skin has been the aim of skin imaging techniques. However, better magnification does not automatically lead to better classification when it is still only the eye that decides, based on color and shape alone.

Health practitioners who examine or treat the skin need an objective, rigorous and repeatable way of characterizing and diagnosing lesions that can be reproduced and matched or compared in other clinical settings. Such a method needs to generate images, but these images must be backed up with spectroscopic data. It is the spectroscopic data, rather than the images, that actually determine the parameters for diagnosis.

About SIMSYS-MoleMate

The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.

Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

For more information about SIMSYS-MoleMate, contact:
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

# # #

We customized marketing and promotional strategies that integrate Business Blogsites, Business Network Marketing, SEO, Email Marketing, Pay-Per-Click Marketing, ICross Media Sales Promotions, Branding and Integrated Marketing Communications.